Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan · Delayed Price · Currency is TWD 35.30
-0.80 (-2.22%)
At close: Jul 9, 2026
TPE:6657 Market Cap
TPE:6657 has a market cap or net worth of 3.1 billion as of July 9, 2026. Its market cap has decreased by -48.15% in one year.
Market Cap
3.10B
Enterprise Value
2.34B
Revenue
7.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.30
Market Cap Chart
Since August 8, 2018, TPE:6657's market cap has increased from 1.02B to 3.10B, an increase of 203.34%. That is a compound annual growth rate of 15.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.10B | -18.60% |
| Dec 31, 2025 | 3.81B | -1.55% |
| Dec 31, 2024 | 3.87B | -15.67% |
| Dec 29, 2023 | 4.59B | 60.69% |
| Dec 30, 2022 | 2.86B | -4.64% |
| Dec 30, 2021 | 3.00B | 2.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovate Biotechnology | 3.74B |
| Formosa Pharmaceuticals | 3.65B |
| Sagittarius Life Science | 3.52B |
| SYN-TECH Chem. & Pharm. | 3.34B |
| BioGend Therapeutics | 3.23B |
| Shine-On BioMedical | 3.23B |
| Chunghwa Chemical Synthesis & Biotech | 3.05B |
| Apex Biotechnology | 2.99B |